Re: Intravenously Administered Magnesium Sulfate To Prevent Labor

From: Meenan, Anna (annam@uic.edu)
Tue Oct 10 14:11:31 2006


Interesting. We use a lot of Mag in this neck of the woods. I have to make a tiny complaint about the fact that, while technically true, the statement about infusing epsom salts intravenously may be just the teensiest bit irresponsible on the part of a lay publication. Conjures up images of injecting IV the stuff that people soak their feet in. Could you send me a copy of the Green Journal article? Would love to get a discussion going with the residents.

Anna Meenan, MD

>.
>
>Intravenously Administered Magnesium Sulfate To Prevent Labor Ineffective,
>Potentially Deadly, Commentary Says
>
>Access this story and related links online:
>http://www.kaisernetwork.org/daily_reports/rep_index.cfm?DR_ID=40292
>
>Magnesium sulfate administered intravenously to a pregnant woman who
>is about to
>deliver a premature infant is an unconfirmed, ineffective and
>potentially fatal
>treatment, David Grimes and Kavita Nanda of Family Health International write
>in an Obstetrics and Gynecology commentary published in the October issue of
>the journal, the Washington Post reports. Infusions of magnesium sulfate, or
>Epsom salts, commonly are administered to pregnant women between 26 and 34
>weeks' gestation for about 48 hours to delay contractions and allow the
>injection of steroids, which increases the rate of fetal lung development.
>According to the Post, magnesium sulfate can cause side effects that include
>blurred vision, burning sensations, headaches, nausea and "profound lethargy."
>In some cases, it can lead to pulmonary edema, a condition in which the lungs
>fill with liquid, the Post reports. The commentary is a response to a study
>conducted by the Cochrane Collaboration that reviewed 23 clinical trials
>conducted worldwide involving 2,000 pregnant women who had received the drug.
>The study finds that the use of magnesium sulfate did not reduce preterm labor
>and that more infants died as a result of administering drug compared with the
>control group. Grimes and Nanda estimate that about 120,000 U.S. women receive
>magnesium sulfate annually and that its use might be associated with 1,900 to
>4,800 fetal deaths annually in the country. According to Grimes, physicians
>seeking to delay premature contractions that can prompt labor should use a
>calcium channel blocker such as nifedipine, which has been proven effective.
>
>Comments
>
>The use of magnesium sulfate is a "North American anomaly" that is
>predicated on
>"good hopes and good wishes rather than good data," Grimes said. For many
>physicians, "there is pressure to use [magnesium sulfate] from patients, as
>well as peer pressure" from other doctors, Gary Cunningham, a professor at the
>University of Texas Southwestern Medical Center, said. He added that the drug
>has a "powerful constituency" and is an effective treatment for other
>conditions -- such as preeclampsia, eclampsia or pregnancy-induced
>hypertension. Michael Gallagher, a maternal and fetal medicine specialist at
>Shady Grove Adventist and Holy Cross hospitals, said, "There is current
>practice (to use the drug) that is the community standard." He added that use
>of magnesium sulfate is a safe and viable option in some cases and is not an
>ineffective and dangerous drug (Boodman, Washington Post, 10/10).
>
>--
>
>Additional Comments by Dean Huffman
>
>1) When I was in practice in Kansas as an MFM, I had a patient
>transferred to me
>from Fort Riley. She was 34 weeks, in labor. She had received MgSO4,
>Terbutaline, and ritrodrine (the only drug ever approved by the FDA for
>labeling as a tocolytic -- no longer on the market) and about 10 liters of
>saline, all IV. I heard about her only when she was in the air. On
>arrival, she
>was in fulminant pulmonary edema. I immediately intubated her, got a pulmonary
>consultation, and stopped all tocolytics. She delivered a few hours later. The
>baby did fine -- needed only a little O2 by mask. The mother died about a week
>later from ARDS.
>
>2) Grimes was one of my examiners for the oral MFM boards.
>
>3) If anybody wants a copy of the article from the Green Journal and does not
>otherwise have access, contact me privately (dean@thehuffpeople.net)
>
>Dean Huffman





use when must restrict search to only the ob-gyn-l forum...
Enter search keywords:
Returns per screen: Require all keywords:

Return to  OB-GYN-L Mail a New Message to the Forum: ob-gyn-l@obgyn.net
Forum Administrator: geffrey.klein@obgyn.net
Report Technical Problems: webmaster@obgyn.net
Last Updated: Thu Oct 2 04:54:35 2008

The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.